GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zylox-Tonbridge Medical Technology Co 2190.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

18.96

-2.22%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.06bn

FY2019FY2025

Net income

CN¥244.4m

FY2019FY2025

Free cash flow

CN¥268.7m

FY2019FY2025

Shareholders' equity

CN¥3.23bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueCN¥1.06bnCN¥910.8mCN¥614.3mCN¥388.9mCN¥207.1mCN¥32.2mCN¥5.7m
Gross profitCN¥762.9mCN¥651.7mCN¥448.1mCN¥294.1mCN¥153.5mCN¥19.0mCN¥1.4m
Research and developmentCN¥246.8mCN¥271.5mCN¥303.8mCN¥271.7mCN¥195.7mCN¥83.9mCN¥61.7m
Operating incomeCN¥196.6mCN¥70.9m−CN¥182.2m−CN¥242.6m−CN¥247.3m−CN¥116.6m−CN¥80.2m
Net incomeCN¥244.4mCN¥116.7m−CN¥91.6m−CN¥132.2m−CN¥232.4m−CN¥116.9m−CN¥77.6m
Diluted earnings per share0.760.36-0.28-0.40-0.70-0.36-0.24

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsCN¥3.58bnCN¥4.02bnCN¥3.93bnCN¥3.79bnCN¥3.78bnCN¥586.6mCN¥241.0m
Cash and short-term investmentsCN¥1.73bnCN¥1.49bnCN¥1.76bnCN¥2.17bnCN¥3.41bnCN¥369.3mCN¥114.2m
Total liabilitiesCN¥344.0mCN¥409.2mCN¥382.1mCN¥185.7mCN¥120.6mCN¥92.3mCN¥48.2m
DebtCN¥62.3mCN¥104.1mCN¥62.9mCN¥14.0mCN¥9.4mCN¥34.2mCN¥23.3m
Shareholders' equityCN¥3.23bnCN¥3.61bnCN¥3.55bnCN¥3.60bnCN¥3.66bnCN¥494.3mCN¥192.8m
Shares outstanding322m328m328m330m330m323m323m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operationsCN¥377.1mCN¥202.6mCN¥114.6m−CN¥106.3m−CN¥135.3m−CN¥95.8m−CN¥61.8m
Capital spending−CN¥108.3m−CN¥222.7m−CN¥222.2m−CN¥169.1m−CN¥104.3m−CN¥52.5m−CN¥48.4m
Free cash flowCN¥268.7m−CN¥20.1m−CN¥107.6m−CN¥275.4m−CN¥239.5m−CN¥148.4m−CN¥110.2m
Dividends paid−CN¥31.8m——————

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥623.3mCN¥575.5mCN¥482.0mCN¥484.8mCN¥426.0mCN¥346.4mCN¥267.9mCN¥211.1m
Gross profitCN¥457.5mCN¥419.8mCN¥343.1mCN¥348.0mCN¥303.7mCN¥249.5mCN¥198.6mCN¥159.7m
Operating incomeCN¥175.4mCN¥116.3mCN¥80.3m−CN¥42.6mCN¥42.6m−CN¥86.6m−CN¥95.6m−CN¥169.8m
Net incomeCN¥179.2mCN¥121.1mCN¥121.2mCN¥36.5mCN¥80.2m−CN¥50.3m−CN¥41.3m−CN¥102.5m
Diluted earnings per share0.560.380.380.110.24-0.15-0.13-0.31
Cash from operations—CN¥230.0mCN¥167.0mCN¥81.0mCN¥121.0mCN¥136.0m−CN¥21.0m−CN¥47.0m
Capital spending—−CN¥59.0m−CN¥55.0m−CN¥80.0m−CN¥141.0m−CN¥88.0m−CN¥133.0m−CN¥76.0m
Free cash flow—CN¥171.0mCN¥112.0mCN¥1.0m−CN¥20.0mCN¥48.0m−CN¥154.0m−CN¥123.0m
Total assetsCN¥3.73bnCN¥3.58bnCN¥4.07bnCN¥4.02bnCN¥4.06bnCN¥3.93bnCN¥3.84bnCN¥3.79bn
Cash and short-term investmentsCN¥1.48bnCN¥1.73bnCN¥1.88bnCN¥1.49bnCN¥1.36bnCN¥1.76bnCN¥1.95bnCN¥2.17bn
DebtCN¥96.4mCN¥62.3mCN¥94.3mCN¥105.8mCN¥94.6mCN¥62.9mCN¥22.7mCN¥16.3m
Shareholders' equityCN¥3.00bnCN¥3.23bnCN¥3.67bnCN¥3.61bnCN¥3.62bnCN¥3.55bnCN¥3.59bnCN¥3.60bn

Financial ratios

Data as of 10 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin72.1%71.6%72.9%75.6%74.1%58.9%
Operating margin18.8%4.6%-14.7%-33.8%-122.6%-361.2%
Net margin23.1%12.8%-14.9%-34.0%-112.2%-363.6%
Return on equity7.6%3.2%-2.6%-3.7%-6.4%-23.7%
Return on assets6.8%2.9%-2.3%-3.5%-6.1%-19.9%
Free cash flow yield7.4%5.4%4.3%0.8%-0.4%-0.6%
Revenue growth35.1%48.3%58.0%87.8%543.9%461.9%
Earnings growth143.7%-227.3%-30.7%-43.1%98.8%50.7%
Current ratio5.98x4.58x5.40x13.56x31.14x7.17x
Debt to equity0.02x0.03x0.02x0.00x0.00x0.08x
Equity ratio90.4%89.8%90.3%95.1%96.8%84.3%
Interest coverage199.51x16.64x-61.94x-156.28x-710.64x-149.85x
R&D as a share of sales23.3%29.8%49.5%69.9%94.5%260.8%
Buybacks as a share of market value2.0%-0.2%0.6%0.1%-2.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue39.6%101.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin71.9%72.6%72.5%—
Operating margin13.6%-5.3%-16.2%—
Net margin18.3%4.6%-6.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings27.331.1-40.4-29.3-33.1
Price to sales6.34.06.09.937.1

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 27 May 2026.

FY2026FY2025
Paid in the year0.220.109

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.